Report an error   


Submitted: 25 August 2011 Modified: 16 January 2017
HERDIN Record #: PCHRD08251102082698

Successful use of intravenous immunoglobulin (IVIg) for antiphospholipid syndrome (APS)- associated Evanes syndrome.

1Sandra  V. NAVARRA,
2Aileen  U. Agbanlog

Abstract

Background: Antiphospholipid syndrome (APS) is an autoimmune, pro-thrombotic disorder in the presence of circulating antiphospholipid antibodies. EvanÊs syndrome is defined as the presence of autoimmune hemolytic anemia and autoimmune thrombocytopenia is strongly associated with APS and presents a difficult management challenge. Although experience remains limited and uncontrolled mainly due to the prohibitive costs of the drug, the use of intravenous immunoglobulin (IVIg) ???? in combination with high dose steroids - may be beneficial - with reported decline in anticardiolipin antibodies - in the treatment of APSrelated manifestations including EvanÊs syndrome, especially when anti-coagulation is contra-indicated. Setting: St. Luke's Medical Center - a tertiary care hospital

1.
Publication Type:
Journal
Publication Sub Type:
Journal Article, Original
Title:
Philippine Journal of Internal Medicine
Frequency:
Semi-Annual
Publication Date:
September-October 2009
Volume:
47
Issue:
5
Page(s):
223-225
Publisher:
Philippine College of Physicians

LocationCall NumberAvailable FormatAvailability
Philippine Council for Health Research and Development Library Box no.48 Fulltext